ABSTRACT
Mice homozygous for the mutation "nude" (nu/nu) are athymic and lack thymus-dependent lymphocytes. Heterozygote (nu/+) controls, which are phenotypically and immunologically normal, and (nu/nu) mice were infected with 1.0 times 10-6 colony-forming units of Phipps strain BCG. In the spleens of nu/+ mice, there was a progressive increase in number of BCG up to the second week, followed by a gradual decline. However, in the nu/nu mice, BCG growth was gradual and continuous until termination of the experiment at 5 weeks. In the lung, significant differences were not noted until after the second week, at which time the nude mice showed a rapid increase (of more than 2 log10) in the number of BCG. However, the number of BCG was not significantly greater in the livers of either group. Changes in the normal histology of the lung included a massive influx of monocytes during the first 2 weeks which peaked at day 21. In the lungs of the nu/+ mice by day 28, there was considerable granuloma formation consisting of monocytes and small lymphocytes. However, in the lungs of nu/nu animals, the granulomas were made up primarily of monocytes with a lack of small lymphocytes. Acid-fast stains confirmed the presence of large numbers of organisms in the macrophages of nu/nu mice, with gradual destruction of these phagocytic cells.
Subject(s)
BCG Vaccine , Mice, Nude/immunology , Mycobacterium Infections/immunology , Mycobacterium bovis/immunology , Animals , Granuloma/etiology , Granuloma/immunology , Granuloma/pathology , Heterozygote , Homozygote , Liver/immunology , Liver/microbiology , Lung/immunology , Lung/microbiology , Lung Diseases/pathology , Lymphocytes/immunology , Mice , Monocytes/immunology , Organ Size , Phagocytosis , Spleen/immunology , Spleen/microbiology , Time FactorsABSTRACT
Clinical and preclinical studies involving several different mammalian species and research paradigms suggest a negative correlation between aggression and central serotonin activity. To test the generalizability of laboratory findings in rhesus monkeys that show a negative correlation between cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations and aggression, we obtained cisternal cerebrospinal fluid and blood plasma samples from monkeys living in naturalistic conditions. During a semiannual trapping, 28 juvenile and adolescent male rhesus monkeys were chosen from a population of 4200 provisioned, free-ranging rhesus monkeys living on Morgan Island, a sea island located off the coast of South Carolina. Based on direct observations of participation or avoidance of aggressive behavior and examinations of apparent fight wounds, 18 monkeys were selected for cerebrospinal fluid taps and blood samples. The remaining 10 monkeys were selected at random. Descriptions of aggressive behavior and the number of old scars and recent wounds were carefully transcribed, and a photograph showing wounds and scars was obtained for each animal. Using the transcriptions and photographs, researchers experienced in rhesus monkey behavior, but blind to the subjects' monoamine and hormone concentrations, were asked to rank the monkeys from the most to the least aggressive. The results showed a significant negative correlation between high rankings for aggression and cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. There was evidence that aggression was associated with stress, in that cerebrospinal fluid, norepinephrine, and plasma corticotropin and cortisol concentrations were positively correlated with high rankings of aggression.
Subject(s)
Adrenocorticotropic Hormone/blood , Aggression/physiology , Hydrocortisone/blood , Hydroxyindoleacetic Acid/cerebrospinal fluid , Macaca mulatta/physiology , Animals , Animals, Wild/physiology , Circadian Rhythm , Macaca mulatta/blood , Macaca mulatta/cerebrospinal fluid , Male , Norepinephrine/cerebrospinal fluid , Serotonin/blood , Stress, Physiological/metabolismABSTRACT
A method is described of using the production of oedema in the foot pad of rats as an index of the ability of pertussis vaccines to cause local reactions. At a suitable time after the subcutaneous injection of the vaccine into hind paw of the rat, the foot is excised and weighed. The technique is reproducible and most useful for the detection of oedema produced by pertussis-vaccine components sensitive to heating at 80 degrees C for 30 min. Substances in pertussis vaccine that produce rat-paw oedema gave maximal reactions at 4 and 12 h. but were best differentiated 9 h after injection.
Subject(s)
Edema/etiology , Pertussis Vaccine/toxicity , Animals , Bacterial Toxins/toxicity , Bordetella pertussis/immunology , Endotoxins/toxicity , Foot , Hindlimb , Hot Temperature , Injections, Subcutaneous , Male , Rats , Rats, Inbred StrainsABSTRACT
Sustained increases in CSF concentrations of the excitotoxin quinolinic acid (QUIN) occur in patients with AIDS and have been implicated in the pathogenesis of the AIDS dementia complex. Macaques in captivity may also develop immunodeficiency syndromes caused by retrovirus infection, including simian retrovirus type-D. In the present study, CSF QUIN concentrations were moderately increased in retrovirus type-D-positive/antibody-negative macaques (163.8 +/- 35.1 nmol/l; P less than 0.0001, n = 21) but not virus-negative/antibody-positive macaques (27.4 +/- 9.4 nmol/l, n = 8) compared to uninfected control macaques (23.0 +/- 1.6 nmol/l; n = 22). CSF QUIN concentrations in virus-positive/antibody-negative macaques tended to remain elevated over a 4-20 month period. Post-mortem studies of 9 virus-positive/antibody-negative macaques and 6 virus-negative/antibody-positive macaques revealed inflammatory responses in the brains of 6 of 9 virus-positive/antibody negative macaques, including lymphocytic infiltrates of the choroid plexus in 3 macaques, glial nodules in 3 macaques and perivascular infiltrates in 1 macaque. These lesions were not extensive and no evidence of brain atrophy was observed. No lesions were observed in the 6 antibody-positive/virus-negative macaques. Small increases in plasma L-kynurenine in virus-positive/antibody-negative macaques are consistent with activation of indoleamine-2,3-dioxygenase, the first enzyme in the kynurenine pathway. We conclude that sustained moderate increases in CSF QUIN occur in viremic simian retrovirus type-D macaques. The increases in CSF QUIN may reflect inflammatory responses within the brain or synthesis of QUIN precursors in systemic tissues, their entry into brain and subsequent conversion to QUIN. The neuropathologic significance of these increases in CSF QUIN remains to be determined.
Subject(s)
Quinolinic Acids/cerebrospinal fluid , Retroviruses, Simian , Simian Acquired Immunodeficiency Syndrome/cerebrospinal fluid , Animals , Brain/microbiology , Brain/pathology , Kynurenic Acid/blood , Macaca mulatta , Quinolinic Acid , Quinolinic Acids/blood , Reference Values , Retroviruses, Simian/isolation & purification , Simian Acquired Immunodeficiency Syndrome/blood , Simian Acquired Immunodeficiency Syndrome/microbiology , Tryptophan/bloodSubject(s)
Monkey Diseases/epidemiology , Toxicology , Animals , Arteriosclerosis/epidemiology , Ascariasis/epidemiology , Dysentery, Amebic/epidemiology , Dysentery, Bacillary/epidemiology , Helminthiasis/epidemiology , Herpesviridae Infections/epidemiology , Models, Biological , Oesophagostomiasis/epidemiology , Pneumonia/epidemiology , Protozoan Infections/epidemiology , Rift Valley Fever/epidemiology , Salmonella Infections, Animal/epidemiology , Species Specificity , Strongyloidiasis/epidemiology , Tuberculosis/epidemiology , Yellow Fever/epidemiologySubject(s)
Trachoma/immunology , Viral Vaccines , Animals , Chlamydia/isolation & purification , Complement Fixation Tests , Conjunctivitis, Inclusion/drug therapy , Conjunctivitis, Inclusion/immunology , Conjunctivitis, Inclusion/microbiology , Conjunctivitis, Inclusion/pathology , Demeclocycline/therapeutic use , Female , Haplorhini , Injections, Intravenous , Injections, Subcutaneous , Male , Papio , Sulfamethoxypyridazine/therapeutic use , Trachoma/drug therapy , Trachoma/microbiology , Trachoma/pathology , Vaccination , Vaccines/administration & dosageSubject(s)
Apicomplexa , Chlorocebus aethiops , Liver Diseases, Parasitic/veterinary , Monkey Diseases/parasitology , Protozoan Infections, Animal/parasitology , Africa/epidemiology , Animals , Liver Diseases, Parasitic/epidemiology , Liver Diseases, Parasitic/pathology , Monkey Diseases/epidemiology , Monkey Diseases/pathology , Protozoan Infections, Animal/epidemiology , Protozoan Infections, Animal/pathologyABSTRACT
The effect of immunization of mothers on the antibody response of their young to pneumococcal type 19F polysaccharide was studied. When 2-week-old BALB/c mice from mothers immunized with 23-valent pneumococcal vaccine during gestation were given an additional dose of the same vaccine, mouse pneumococcal antiserum, or both, they produced higher titers of antibodies to the 19F polysaccharide (1.87 to 4.66 micrograms of 19F immunoglobulin M [IgM] antibody per ml of serum; 0.45 to 0.81 micrograms of IgG antibody per ml of serum) than the control group that did not receive any treatment after birth (0.69 micrograms of 19F IgM antibody per ml; 0.28 micrograms of 19F IgG antibody per ml) (P less than 0.01). Furthermore, all 11- to 12-week-old monkeys that received an additional dose of 23-valent vaccine, pneumococcal immunoglobulin, or both produced statistically higher titers of IgG antibody to the 19F polysaccharide than did controls at various ages. The titers (micrograms of IgG antibody per milliliter of serum) were as follows: vaccine group, 7.12 +/- 0.96; control group at 4 months of age, 3.82 +/- 0.74 (P less than 0.01); immunoglobulin-treated group, 6.85 +/- 0.76; vaccinated and immunoglobulin-treated group, 7.80 +/- 1.40; control group at 3 months of age, 3.01 +/- 0.61 (P less than 0.01). These results suggest that immunization of mothers under certain conditions, such as with an optimum dose of antigen at a critical period of gestation or postnatal development, could provide young infants with an enhanced antibody response to pneumococcal polysaccharide immunogens.
Subject(s)
Antibodies, Bacterial/biosynthesis , Immunity, Maternally-Acquired , Polysaccharides, Bacterial/immunology , Streptococcus pneumoniae/immunology , Animals , Animals, Newborn , Antigens, Bacterial , Female , Immunization , Immunoglobulin G/biosynthesis , Immunoglobulin M/biosynthesis , Macaca mulatta , Mice , Mice, Inbred BALB C , PregnancyABSTRACT
Pygmy marmosets were inoculated with the low-passage parental strain or with the attenuated variant of OKA strain of varicella-zoster virus. No clinical signs were observed following inoculation and virus could not be isolated from tissues taken at several times after inoculation. A low-level antibody response developed in all animals. Three months after the first inoculation, all animals were challenged with the low-passage parental strain of virus. Animals primed originally with the parental strain developed higher booster responses than animals primed with the attenuated strain of virus. The results suggest that the parental and attenuated strains of varicella-zoster virus differ in their immunogenicity in pygmy marmosets.
Subject(s)
Antibody Formation , Callitrichinae/microbiology , Herpesvirus 3, Human/immunology , Vaccines, Attenuated/immunology , Animals , Herpesvirus 3, Human/growth & development , Virus ReplicationABSTRACT
The Caribbean Primate Research Center recently contracted with the Food and Drug Administration to establish a free-ranging island breeding colony of rhesus monkeys. The goal of the program is to produce 600 to 800 offspring yearly from 1,000 breeding age females. The initial colony stock will consist of approximately 360 animals from an existing colony that was established on an island off the southwestern coast of Puerto Rico in 1961. Expansion of the colony will be accomplished by the purchase and introduction of rhesus females obtained from the wild. The colony site, reproductive history, composition, and the methodology of our expansion plans are discussed. In addition, anticipated problems are identified and analyzed.
Subject(s)
Macaca mulatta/physiology , Macaca/physiology , Animals , Breeding , Female , Haplorhini , Homing Behavior , Housing, Animal , Male , Population , Puerto Rico , Quarantine , Rain , Reproduction , Seasons , Social Behavior , TreesABSTRACT
Moustached marmosets (Saguinus mystax) were infected intranasally with either of two low-passaged, wildlike strains of measles virus, strain Edmonston or strain JM. The infection resulted in 25 and 100% mortality, respectively, 12 to 14 days after infection. Clinical signs, gross pathological findings, and histology lacked the characteristic features of measles in other primates. A deficient immune response and widespread gastroenterocolitis appeared to be the main causes for the fatal outcome. Fluorescent-antibody staining detected large amounts of measles antigen in lymphatic tissues, the gastrointestinal and respiratory tracts, the salivary glands, pancreas, liver, kidney, and other visceral tissues. Live attenuated or inactivated measles vaccine proved equally effective in preventing fatal measles in marmosets. Challenge with live virus of animals which were primed 1 year previously with inactivated alum-absorbed vaccine resulted in a precipitous response, with a 100- to 1,000-fold increase in antibody titers. This vigorous booster response suggests the existence of a primary deficiency in lymphocyte cooperation in marmosets, which upon adequate priming is followed by extensive clonal expansion and antibody synthesis. Marmosets appear to be the most susceptible primate species to measles infection. They are capable of distinguishing differences in virulence of virus strains with a level of sensitivity not available in other animals.
Subject(s)
Measles Vaccine/immunology , Measles virus/pathogenicity , Measles/microbiology , Vaccines, Attenuated/immunology , Animals , Antibodies, Viral/analysis , Antigens, Viral/analysis , Callitrichinae , Haplorhini , Measles/pathology , Measles/prevention & control , Measles virus/immunology , Sepsis/complicationsABSTRACT
We investigated an immunodeficient child in whom chronic progressive poliomyelitis developed after she had received live oral poliovirus vaccine. Poliovirus, Type II, was isolated from throat and stool during life and from several sites within the brain at autopsy. The brain isolate was classified as vaccine-like on the basis of temperature sensitivity and antigenic markers. However, in the monkey neurovirulence test, the brain isolate produced moderately severe lesions throughout the spinal cord and brainstem and appeared nonvaccine-like. Thus, the brain isolate demonstrated a dissociation between the antigenic and neurovirulence markers. Our observations suggest that, under unusual circumstances, such as immunodeficiency, attenuated poliovirus can produce a chronic progressive neurologic disease. This case also emphasizes the need to diagnose immunodeficiency as early as possible, so that live-virus vaccines will not be administered.
Subject(s)
Agammaglobulinemia/complications , Poliomyelitis/etiology , Poliovirus Vaccine, Oral/adverse effects , Agammaglobulinemia/immunology , B-Lymphocytes/immunology , Chronic Disease , Feces/microbiology , Female , Humans , Infant , Pharynx/microbiology , Poliomyelitis/pathology , Poliovirus/isolation & purification , T-Lymphocytes/immunology , Thalamus/microbiology , Vaccines, Attenuated/adverse effectsABSTRACT
Quinolinic acid (QUIN), kynurenic acid (KYNA) and L-kynurenine (L-KYN) are neuroactive kynurenine pathway metabolites that accumulate in inflammatory neurological diseases. These increases were attributed to the induction of indoleamine-2,3-dioxygenase (IDO), the enzyme that converts L-tryptophan into L-KYN. Direct conversion of L-tryptophan into QUIN by brain tissue occurs in conditions of CNS inflammation, but not by normal brain tissue. To investigate whether increased activity of enzymes distal to IDO may determine L-KYN conversion to QUIN, rhesus macaques were inoculated with poliovirus directly into the spinal cord, as a model of focal inflammatory neurological disease (FASEB J. 6, 2977-2989, 1992). Induction of spinal cord IDO (35.9-fold) accompanied smaller, but proportional increases in kynurenine-3-hydroxylase (2.4-fold) and kynureninase (2.3-fold) activities, which were correlated to CSF and tissue QUIN levels, as well as to measures of inflammatory lesions. 3-Hydroxyanthranilate-3,4-dioxygenase activity was unchanged. Cerebrospinal fluid KYNA levels increased in proportion to both IDO activity and L-KYN accumulation, though kynurenine aminotransferase activity was unaffected. Cerebrospinal fluid neopterin, a marker of macrophage and immune activation, accumulated in proportion to the responsive enzymes and metabolites. The cell types involved in producing QUIN were investigated in vitro. Human foetal brain cultures consisting of astrocytes and neurons converted large quantities of [13C6]L-tryptophan into L-KYN when stimulated by gamma-interferon, but very little [13C6]QUIN was formed unless macrophages (THP-1 cells) were first added to the cultures (to model a key component of brain inflammation). [13C6]L-Tryptophan was converted into [13C6]QUIN by either gamma-interferon stimulated macrophages, or following intracisternal administration into poliovirus-infected macaques. Inhibitors of the kynurenine pathway, 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilic acid, attenuated [13C6]QUIN formation by macrophages, and when co-infused with [13C6]L-tryptophan into poliovirus-infected macaques. These results suggest roles for increased activities of IDO, kynurenine-3-hydroxylase and kynureninase in accelerating the synthesis of QUIN, L-KYN and KYNA in conditions of brain inflammation. Macrophage infiltrates, and perhaps microglia, are important sources of QUIN, whereas constitutive brain cells and macrophages are sources of L-KYN. Drugs that inhibit kynurenine pathway enzymes attenuate QUIN formation in the CNS, and provide tools to examine the consequences of reduced QUIN accumulation.
Subject(s)
Encephalitis/metabolism , Kynurenic Acid/metabolism , Kynurenine/metabolism , Myelitis/metabolism , Quinolinic Acid/metabolism , 3-Hydroxyanthranilic Acid/analogs & derivatives , 3-Hydroxyanthranilic Acid/pharmacology , Animals , Biopterins/analogs & derivatives , Biopterins/analysis , Brain/metabolism , Encephalitis/enzymology , Fetus/metabolism , Indoleamine-Pyrrole 2,3,-Dioxygenase , Kynurenic Acid/analysis , Kynurenine/analysis , Macaca mulatta , Myelitis/enzymology , Neopterin , Poliomyelitis/enzymology , Poliomyelitis/metabolism , Quinolinic Acid/analysis , Tryptophan/analogs & derivatives , Tryptophan/metabolism , Tryptophan/pharmacology , Tryptophan Oxygenase/metabolismABSTRACT
Nitric oxide has been proposed to mediate cytotoxic effects in inflammatory diseases. To investigate the possibility that overproduction of nitric oxide might play a role in the neuropathology of inflammatory and noninflammatory neurological diseases, we compared levels of the markers of nitric oxide, nitrite plus nitrate, in the CSF of controls with those in patients with various neurologic diseases, including Huntington's and Alzheimer's disease, amyotrophic lateral sclerosis, and HIV infection. We found that there were no significant increases in the CSF levels of these nitric oxide metabolites, even in patients infected with HIV or in monkeys infected with poliovirus, both of which have significantly elevated levels of the neurotoxin quinolinic acid and the marker of macrophage activation, neopterin. However, CSF quinolinic acid, neopterin, and nitrite/nitrate levels were significantly increased in a small group of patients with bacterial and viral meningitis.
Subject(s)
Nervous System Diseases/cerebrospinal fluid , Nitrates/cerebrospinal fluid , Nitrites/cerebrospinal fluid , Alzheimer Disease/cerebrospinal fluid , Amyotrophic Lateral Sclerosis/cerebrospinal fluid , Animals , Biopterins/analogs & derivatives , Biopterins/cerebrospinal fluid , HIV Infections/cerebrospinal fluid , Humans , Huntington Disease/cerebrospinal fluid , Macaca mulatta , Neopterin , Nitric Oxide/metabolism , Quinolinic Acid/cerebrospinal fluidABSTRACT
Accumulation of the neurotoxin quinolinic acid within the brain occurs in a broad spectrum of patients with inflammatory neurologic disease and may be of neuropathologic significance. The production of quinolinic acid was postulated to reflect local induction of indoleamine 2,3-dioxygenase by cytokines in reactive cells and inflammatory cell infiltrates within the central nervous system. To test this hypothesis, macaques received an intraspinal injection of poliovirus as a model of localized inflammatory neurologic disease. Seventeen days later, spinal cord indoleamine 2,3-dioxygenase activity and quinolinic acid concentrations in spinal cord and cerebrospinal fluid were both increased in proportion to the degree of inflammatory responses and neurologic damage in the spinal cord, as well as the severity of motor paralysis. The absolute concentrations of quinolinic acid achieved in spinal cord and cerebrospinal fluid exceeded levels reported to kill spinal cord neurons in vitro. Smaller increases in indoleamine 2,3-dioxygenase activity and quinolinic acid concentrations also occurred in parietal cortex, a poliovirus target area. In frontal cortex, which is not a target for poliovirus, indoleamine 2,3-dioxygenase was not affected. A monoclonal antibody to human indoleamine 2,3-dioxygenase was used to visualize indoleamine 2,3-dioxygenase predominantly in grey matter of poliovirus-infected spinal cord, in conjunction with local inflammatory lesions. Macrophage/monocytes in vitro synthesized [13C6]quinolinic acid from [13C6]L-tryptophan, particularly when stimulated by interferon-gamma. Spinal cord slices from poliovirus-inoculated macaques in vitro also converted [13C6]L-tryptophan to [13C6]quinolinic acid. We conclude that local synthesis of quinolinic acid from L-tryptophan within the central nervous system follows the induction of indoleamine-2,3-dioxygenase, particularly within macrophage/microglia. In view of this link between immune stimulation and the synthesis of neurotoxic amounts of quinolinic acid, we propose that attenuation of local inflammation, strategies to reduce the synthesis of neuroactive kynurenine pathway metabolites, or drugs that interfere with the neurotoxicity of quinolinic acid offer new approaches to therapy in inflammatory neurologic disease.
Subject(s)
Brain/metabolism , Poliomyelitis/metabolism , Poliovirus , Quinolinic Acids/metabolism , Tryptophan Oxygenase/biosynthesis , Animals , Enzyme Induction , Immunohistochemistry , Interferon-gamma/pharmacology , Macaca , Quinolinic Acid , Tryptophan/metabolismABSTRACT
The effect of molecular weight or size of the components on the immunogenicity of polysaccharide-protein conjugates prepared with the native Vi capsular polysaccharide (Vi) (approximately 3 x 10(3) kilodaltons) or lower-molecular-weight Vi (Vis; approximately 46 kilodaltons) abound to cholera toxin (CT) or to its B subunit (CTB) was studied. In mice, Vi-CT, Vi-CTB, and Vis-CTB elicited higher Vi antibody levels than the Vi alone (P less than 0.0001). Vi-CT and Vi-CTB were more immunogenic than Vis-CTB (P less than 0.01). CT or Vi-CT elicited higher levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, than did CTB or Vi-CTB. In rhesus monkeys, the Vi conjugates elicited higher Vi antibody levels than the Vi alone (P less than 0.01). Vi-CTB elicited higher levels of Vi antibody after each injection than did Vis-CTB. Similar levels of CT antibodies, as measured by enzyme-linked immunosorbent assay, were elicited by all three conjugates. In contrast, Vi-CT elicited higher levels of neutralizing antibodies than Vi-CTB or Vis-CTB when either CT or the related heat-labile toxin of Escherichia coli was used as the antigen. These results indicate that the holotoxin and the native Vi provide the most immunogenic components for conjugates designed to induce both Vi and CT antibodies.
Subject(s)
Antibodies, Bacterial/biosynthesis , Polysaccharides, Bacterial/immunology , Typhoid-Paratyphoid Vaccines/immunology , Adjuvants, Immunologic , Animals , Antitoxins/biosynthesis , Cholera Toxin/immunology , Macaca mulatta , Mice , Molecular Weight , Salmonella typhi/immunologyABSTRACT
Apolipoproteins in cerebrospinal fluid (CSF) might have important functional roles in the pathophysiology of brain and lipid metabolism in the vascular component. The present study examined apolipoprotein A-I (apo-A-I) and apolipoprotein E (apo-E) levels in CSF and serum from poliovirus-infected macaques. Poliovirus-infected macaques developed motor deficits and were classified into three groups: (1) muscle weakness in one or both legs; (2) partial paralysis in one or both legs; (3) complete paralysis in one or both legs. No motor deficits were evident in the control or sham-treated macaques. Apo-A-I concentrations in CSF were markedly elevated in poliovirus-infected macaques with weakness, partial or complete paralysis, in comparison with either control or sham-treated animals, and were proportional to the severity of motor impairment. Apo-E concentrations in CSF were also significantly elevated in poliovirus-infected macaques with complete paralysis. The magnitude of increase in CSF apo-A-I or apo-E concentrations was also closely associated with the degree of histologic neurological damage and inflammation (lesion scores). However, no changes in serum apo-A-I and apo-E concentrations were observed in the poliovirus-infected macaques compared with control macaques. Furthermore there were no significant correlations apo-A-I or apo-E concentrations between serum and CSF. We hypothesize that the elevation of apo-A-I and apo-E concentrations after poliovirus infection is caused by immune stimulation within the central nervous system (CNS). Measures of CSF apo-A-I and apo-E levels might serve as a useful marker for the severity and/or the range of CNS injury.